• Nasdaq confirmed on Sept. 11, 2026 that Celularity regained compliance with minimum bid price and market value of listed securities rules.
• A separate Nasdaq deficiency remains open over delayed SEC periodic filings under Listing Rule 5250(c)(1).
• Celularity is working to complete the overdue filings to restore compliance with Nasdaq’s reporting requirement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celularity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-042495), on September 14, 2026, and is solely responsible for the information contained therein.